InsidersTradesSigma
Track the Arch Biopartners Inc. stock price and the full management transaction log of the company, a listed equity based in Canada. Shares are listed on CA CA, under the oversight of SEDI. The latest transaction was filed on 30 June 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Muruve, Richard Gabriel. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Arch Biopartners Inc. is a biotechnology company focused on developing innovative treatments for serious diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.